The expressions and m(6)A methylation modification patterns of mRNAs and lncRNAs in major depressive disorder.
- Open access
Altered m(6)A methylation patterns in mRNAs and lncRNAs are significantly associated with major depressive disorder, affecting over 600 RNAs in patient blood samples.
- Why it matters: Understanding epitranscriptomic modifications like m(6)A in MDD can reveal novel biomarkers and pathways involved in the disorder's pathology, addressing gaps in molecular mechanisms.
- What they did: The study analyzed peripheral blood from 4 untreated MDD patients and 4 controls using microarray profiling to identify differential m(6)A methylation, validated key RNAs in 15 patients and controls.
- The result: Findings highlight specific m(6)A methylation changes in genes such as GRM4 and PAX8-AS1, implicating neuroactive ligand-receptor and AMPK pathways, which may serve as biomarkers or therapeutic targets.